These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 31773687)
1. High expression of SHMT2 is correlated with tumor progression and predicts poor prognosis in gastrointestinal tumors. Liu Y; Yin C; Deng MM; Wang Q; He XQ; Li MT; Li CP; Wu H Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9379-9392. PubMed ID: 31773687 [TBL] [Abstract][Full Text] [Related]
2. High Expression of Serine Hydroxymethyltransferase 2 Indicates Poor Prognosis of Gastric Cancer Patients. Shi H; Fang X; Li Y; Zhang Y Med Sci Monit; 2019 Oct; 25():7430-7438. PubMed ID: 31581160 [TBL] [Abstract][Full Text] [Related]
3. Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker. Zhang L; Chen Z; Xue D; Zhang Q; Liu X; Luh F; Hong L; Zhang H; Pan F; Liu Y; Chu P; Zheng S; Lou G; Yen Y Oncol Rep; 2016 Nov; 36(5):2489-2500. PubMed ID: 27666119 [TBL] [Abstract][Full Text] [Related]
4. Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells. Ji L; Tang Y; Pang X; Zhang Y Med Sci Monit; 2019 Aug; 25():5823-5832. PubMed ID: 31379360 [TBL] [Abstract][Full Text] [Related]
5. Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors. Bernhardt S; Bayerlová M; Vetter M; Wachter A; Mitra D; Hanf V; Lantzsch T; Uleer C; Peschel S; John J; Buchmann J; Weigert E; Bürrig KF; Thomssen C; Korf U; Beissbarth T; Wiemann S; Kantelhardt EJ Breast Cancer Res; 2017 Oct; 19(1):112. PubMed ID: 29020998 [TBL] [Abstract][Full Text] [Related]
6. SHMT2 Drives the Progression of Colorectal Cancer by Regulating UHRF1 Expression. Cui X; Cui Y; Du T; Jiang X; Song C; Zhang S; Ma C; Liu Y; Ni Q; Gao Y; Wang G Can J Gastroenterol Hepatol; 2022; 2022():3758697. PubMed ID: 35211429 [TBL] [Abstract][Full Text] [Related]
7. Mitochondrial serine hydroxymethyltransferase 2 is a potential diagnostic and prognostic biomarker for human glioma. Wang B; Wang W; Zhu Z; Zhang X; Tang F; Wang D; Liu X; Yan X; Zhuang H Clin Neurol Neurosurg; 2017 Mar; 154():28-33. PubMed ID: 28107674 [TBL] [Abstract][Full Text] [Related]
8. The expression and clinical significance of serine hydroxymethyltransferase2 in gastric cancer. Shan Y; Liu D; Li Y; Wu C; Ye Y PeerJ; 2024; 12():e16594. PubMed ID: 38188143 [TBL] [Abstract][Full Text] [Related]
9. Cancer proteome and metabolite changes linked to SHMT2. Tong J; Krieger JR; Taylor P; Bagshaw R; Kang J; Jeedigunta S; Wybenga-Groot LE; Zhang W; Badr H; Mirhadi S; Pham NA; Coyaud É; Yu M; Li M; Cabanero M; Raught B; Maynes JT; Hawkins C; Tsao MS; Moran MF PLoS One; 2020; 15(9):e0237981. PubMed ID: 32903271 [TBL] [Abstract][Full Text] [Related]
10. miR-615-5p prevents proliferation and migration through negatively regulating serine hydromethyltransferase 2 (SHMT2) in hepatocellular carcinoma. Wu X; Deng L; Tang D; Ying G; Yao X; Liu F; Liang G Tumour Biol; 2016 May; 37(5):6813-21. PubMed ID: 26662310 [TBL] [Abstract][Full Text] [Related]
11. SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma. Ning S; Ma S; Saleh AQ; Guo L; Zhao Z; Chen Y Gastroenterol Res Pract; 2018; 2018():4369253. PubMed ID: 30228815 [TBL] [Abstract][Full Text] [Related]
13. SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling. Wang W; Wang M; Du T; Hou Z; You S; Zhang S; Ji M; Xue N; Chen X Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108312 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of SHMT2 promotes the prostate cancer proliferation and metastasis by inducing epithelial-mesenchymal transition. Chen L; Liu H; Ji Y; Ma Z; Shen K; Shangguan X; Qian H; Zhao Y; Pan CW; Xue W Exp Cell Res; 2022 Jun; 415(2):113138. PubMed ID: 35398308 [TBL] [Abstract][Full Text] [Related]
15. Deacetylation of serine hydroxymethyl-transferase 2 by SIRT3 promotes colorectal carcinogenesis. Wei Z; Song J; Wang G; Cui X; Zheng J; Tang Y; Chen X; Li J; Cui L; Liu CY; Yu W Nat Commun; 2018 Oct; 9(1):4468. PubMed ID: 30367038 [TBL] [Abstract][Full Text] [Related]
16. Positive correlation between expression level of mitochondrial serine hydroxymethyltransferase and breast cancer grade. Yin K Onco Targets Ther; 2015; 8():1069-74. PubMed ID: 25999742 [TBL] [Abstract][Full Text] [Related]
17. Serine catabolism regulates mitochondrial redox control during hypoxia. Ye J; Fan J; Venneti S; Wan YW; Pawel BR; Zhang J; Finley LW; Lu C; Lindsten T; Cross JR; Qing G; Liu Z; Simon MC; Rabinowitz JD; Thompson CB Cancer Discov; 2014 Dec; 4(12):1406-17. PubMed ID: 25186948 [TBL] [Abstract][Full Text] [Related]
18. SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation. Yang X; Wang Z; Li X; Liu B; Liu M; Liu L; Chen S; Ren M; Wang Y; Yu M; Wang B; Zou J; Zhu WG; Yin Y; Gu W; Luo J Cancer Res; 2018 Jan; 78(2):372-386. PubMed ID: 29180469 [TBL] [Abstract][Full Text] [Related]
19. Serine hydroxymethyltransferase 2: a novel target for human cancer therapy. Xie M; Pei DS Invest New Drugs; 2021 Dec; 39(6):1671-1681. PubMed ID: 34215932 [TBL] [Abstract][Full Text] [Related]
20. Evaluating the clinical significance of SHMT2 and its co-expressed gene in human kidney cancer. Wang H; Chong T; Li BY; Chen XS; Zhen WB Biol Res; 2020 Oct; 53(1):46. PubMed ID: 33066813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]